Filing Details
- Accession Number:
- 0001125345-24-000055
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-06 16:19:33
- Reporting Period:
- 2024-03-04
- Accepted Time:
- 2024-03-06 16:19:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1125345 | Macrogenics Inc | MGNX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1675464 | Thomas Spitznagel | 9704 Medical Center Drive Rockville MD 20850 | Sr Vp, Technical Ops | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-03-04 | 10,000 | $11.50 | 18,316 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-03-04 | 10,000 | $20.00 | 8,316 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee stock option (right to buy) | Disposition | 2024-03-04 | 10,000 | $0.00 | 10,000 | $11.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
77,000 | 2030-02-20 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/17/2023.
- 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.